Idexx Laboratories, Inc.
NASDAQ:IDXX 12:47:41 PM EDT
Other Pre-Announcement
Idexx Laboratories Announces First Quarter Results
Published: 05/04/2022 10:42 GMT
Idexx Laboratories, Inc. (IDXX) - Idexx Laboratories Announces First Quarter Results.
Q1 Earnings per Share $2.27.
Q1 Revenue Rose 8 Percent to $837 Million.
Qtrly EPS of $2.27.
Qtrly EPS Results Included $0.06 per Share in Tax Benefits.
Qtrly Revenue $836.5 Million Versus $777.7 Million.
Q1 Earnings per Share View $2.26, Revenue View $839.7 Million -- Refinitiv Ibes Data (analyst estimates).
Re-calibrated 2022 Revenue Outlook Reflects 5.5% - 8% Reported Growth and 7.5% - 10% Organic.
Sees 2022 EPS $8.11-$8.35.
FY Revenue Outlook Reflects About $10 Million in Projected Revenue Reductions Related to War in Ukraine, Among Other Things.
FY2022 Earnings per Share View $9.44, Revenue View $3.54 Billion -- Refinitiv Ibes Data (analyst estimates).
Q1 Earnings per Share $2.27.
Q1 Revenue Rose 8 Percent to $837 Million.
Qtrly EPS of $2.27.
Qtrly EPS Results Included $0.06 per Share in Tax Benefits.
Qtrly Revenue $836.5 Million Versus $777.7 Million.
Q1 Earnings per Share View $2.26, Revenue View $839.7 Million -- Refinitiv Ibes Data (analyst estimates).
Re-calibrated 2022 Revenue Outlook Reflects 5.5% - 8% Reported Growth and 7.5% - 10% Organic.
Sees 2022 EPS $8.11-$8.35.
FY Revenue Outlook Reflects About $10 Million in Projected Revenue Reductions Related to War in Ukraine, Among Other Things.
FY2022 Earnings per Share View $9.44, Revenue View $3.54 Billion -- Refinitiv Ibes Data (analyst estimates).